But is the potential combo a reaction to Amazon's (AMZN - Get Report) dive into healthcare? Amazon recently obtained wholesale distribution licenses from pharmaceutical boards in multiple states, including New Jersey, Connecticut, Michigan and Arizona. It's also reportedly in preliminary talks with generic drugmakers including Mylan NV and Sandoz (NVS - Get Report) The question is, what will the master of disruption do next?
It's your move, Jeff Bezos.
More of What's Trending on TheStreet:
- Trump Tax Plan Makes This Sector of the Stock Market Potentially Explosive
- Seven Great Holiday Gift Ideas from a Financial Advisor -- and Mom
- Anyone Who Resists the Rise of Legal Cannabis Is Among Dumbest on Wall Street
- Investing Like Warren Buffett Comes With a Big Challenge That Can't Be Overcome